Head To Head Clinical Trial Indicate Similar Safety Profile In Diabetic Patients For CYPHER® Sirolimus Eluting Coronary Stent
A subgroup analysis of diabetic patient data from a two-year randomized controlled trial comparing the CYPHER® Sirolimus-eluting Coronary Stent to the Taxus Stent showed no statistically significant differences in safety outcomes between the two drug-eluting stents. [click link for full article]
More: continued here
Filed under: Cardiovascular on September 12th, 2007